Diagnostic Impacts of Clinical Laboratory-Based [-2] proPSA Indices on Any Grade, Gleason Grade Group ≥2 or ≥3 of Prostate Cancer in the PSA Below 10 ng/mL

Kazuto Ito,Akira Yokomizo,Shoji Tokunaga,Gaku Arai,Mikio Sugimoto,Koichiro Akakura,Hisashi Hasumi,Hideki Sakai,Akiko Ouraji,Ryo Oki,Eiji Kashiwagi,Yoshitomo Kobori,Hiromi Hirama,Hiroki Kitoh,Hiroji Uemura,Tomoaki Hakariya,Kazuhiro Suzuki

Diagnostic Impacts of Clinical Laboratory-Based [-2] proPSA Indices on Any Grade, Gleason Grade Group ≥2 or ≥3 of Prostate Cancer in the PSA Below 10 ng/mL

2019

Kazuto Ito
Akira Yokomizo
Shoji Tokunaga
Gaku Arai
Mikio Sugimoto
Koichiro Akakura
Hisashi Hasumi
Hideki Sakai
Akiko Ouraji
Ryo Oki
Eiji Kashiwagi
Yoshitomo Kobori
Hiromi Hirama
Hiroki Kitoh
Hiroji Uemura
Tomoaki Hakariya
Kazuhiro Suzuki

Purpose:PROPHET is a prospective study in order to clarify a diagnostic impact of laboratory-based and prostate volume-adjusted [-2]proPSA-related indices on prostate cancer and a clinically signif...

Keywords:

Gleason grade
Urology
Prospective cohort study
Prostate cancer
Prostate
Medicine
health index
Hematologic tests
Prostate-specific antigen
mass screening

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations